8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
West Pharmaceutical says Mr.
Filed with the SEC on · Summarized by InvestorsBot
West Pharmaceutical says Mr. Green intends to retire from the Company and the Board; press release furnished as Exhibit 99.1. Filing dated 2026-03-09. $WST 👤🏛️ #WST #leadership
Company reaffirms its 2026 financial guidance as provided in the Feb 12, 2026 earnings release; update included in Exhibit 99.1—no change to guidance as of 2026-03-09. $WST 📈📢 #WST #guidance #pharma
Disclosure in Item 7.01 (and Exhibit 99.1) is furnished, not “filed” under Exchange Act Section 18, and is not incorporated by reference into other SEC filings. ⚖️ #WST #disclosure